|View printer-friendly version|
|LabCorp Receives 2017 Partnership Award from Be The Match®|
Award Recognizes 25 Years of Innovation and Support to Help Cure Blood Cancers
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171113005674/en/
Be The Match, operated by the National Marrow Donor Program® (NMDP), is the world’s leading nonprofit organization focused on saving lives through marrow and cord blood transplantation, which can be a cure for someone with life-threatening blood cancers like leukemia or lymphoma. The nonprofit organization also runs the Be The Match Registry®, the world’s largest registry of potential bone marrow donors and donated cord blood units. Since 1987, Be The Match has made more than 80,000 transplants possible.
“LabCorp has been an exemplary partner from the very beginning of our
LabCorp and Be The Match have worked closely together to improve the quality, efficiency and convenience of donor match testing, which assesses the patient’s and donor’s human leukocyte antigen (HLA, or tissue type) to identify tissue donations most likely to be accepted by the patient, helping to improve treatment success. During their collaboration, LabCorp has continually enhanced the quality and convenience of HLA testing, including the introduction of DNA-based molecular HLA testing and buccal swab specimen collection in place of traditional venous blood collection. Be The Match worked with LabCorp on a pilot program to evaluate the new collection method, and it now uses buccal swabs for all of its donor collections, making it easier for potential donors to be added to the Be The Match Registry. Throughout their partnership, LabCorp’s nationwide network of collection sites and standardized testing have provided Be The Match with a single lab to support the full range of testing needs for donors and patients.
Their joint efforts have also helped to expand the donor database by publicizing the need for more potential donors to be tested, with LabCorp hosting donor drives for its employees and welcoming Be The Match recipients to tell their stories at LabCorp events. LabCorp has also sponsored many fundraising drives to support the donor registry program. By working closely together for more than a quarter century, LabCorp and Be The Match have helped to make better matches and expand the donor database, improving outcomes for more patients.
“LabCorp is honored to receive this award from our great friends at Be
The Match,” said
LabCorp (NYSE: LH), an
This press release contains forward-looking statements including with
respect to estimated 2017 guidance and the impact of various factors on
operating and financial results. Each of the forward-looking statements
is subject to change based on various important factors, including
without limitation, competitive actions in the marketplace, and adverse
actions of governmental and other third-party payers. Actual results
could differ materially from those suggested by these forward-looking
statements. The Company has no obligation to provide any updates to
these forward-looking statements even if its expectations change.
Further information on potential factors that could affect operating and
financial results is included in the Company’s Form 10-K for the year
About Be The Match
For people with life-threatening blood cancers—like leukemia and lymphoma—or other diseases, a cure exists. Be The Match connects patients with their donor match for a life-saving marrow or umbilical cord blood transplant. People can contribute to the cure as a member of the Be The Match Registry, financial contributor or volunteer. Be The Match provides patients and their families one-on-one support, education, and guidance before, during and after transplant.
Be The Match is operated by the National Marrow Donor Program® (NMDP), a nonprofit organization that matches patients with donors, educates health care professionals and conducts research so more lives can be saved. To learn more about the cure, visit BeTheMatch.org or call 1 (800) MARROW-2.
|Print Page | E-mail Page | RSS Feeds | E-mail Alerts | IR Contacts | Tear Sheet|